Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates

Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates A group of 27 first infused haemophiliacs was studied for association between heat‐treated clotting factor concentrates and transmission of human parvovirus B19. The prevalence rate of B19 antibody, detected by the Immunoelectroosmophoresis (IEOP) reaction, was 55.5% in this group of first infused subjects, significantly higher than the 29.3% of the control group of 58 healthy blood donors but lower than the 93.3% of antibody positive subjects in a group of 30 haemophiliacs multitreated with unheated products. Five of 17 B19 antibody negative patients produced human parvovirus IgM, detectable by radioimmunoassay, after the first treatment with heated concentrates; two of them developed viraemia 6 and 10 days, respectively, after the first infusion dose. These results lead to the conclusion that human parvovirus is transmissible by blood derivatives even when they have been exposed to steam‐ or dry‐heat treatment. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Medical Virology Wiley

Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates

Loading next page...
 
/lp/wiley/human-parvovirus-infection-in-haemophiliacs-first-infused-with-treated-PRk9oLpVV6

References (20)

Publisher
Wiley
Copyright
Copyright © 1988 Wiley‐Liss, Inc., A Wiley Company
ISSN
0146-6615
eISSN
1096-9071
DOI
10.1002/jmv.1890250206
Publisher site
See Article on Publisher Site

Abstract

A group of 27 first infused haemophiliacs was studied for association between heat‐treated clotting factor concentrates and transmission of human parvovirus B19. The prevalence rate of B19 antibody, detected by the Immunoelectroosmophoresis (IEOP) reaction, was 55.5% in this group of first infused subjects, significantly higher than the 29.3% of the control group of 58 healthy blood donors but lower than the 93.3% of antibody positive subjects in a group of 30 haemophiliacs multitreated with unheated products. Five of 17 B19 antibody negative patients produced human parvovirus IgM, detectable by radioimmunoassay, after the first treatment with heated concentrates; two of them developed viraemia 6 and 10 days, respectively, after the first infusion dose. These results lead to the conclusion that human parvovirus is transmissible by blood derivatives even when they have been exposed to steam‐ or dry‐heat treatment.

Journal

Journal of Medical VirologyWiley

Published: Jun 1, 1988

There are no references for this article.